Quick Takeaways
- BML Investment Partners, L.P. filed SCHEDULE 13G/A for ESSA Pharma Inc. Common Shares, no par value per share (EPIX).
- Disclosed ownership: 9.4%.
- Date of event: 31 Dec 2024.
BML Investment Partners, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for ESSA Pharma Inc. Common Shares, no par value per share (EPIX)
- Filing Manager
- BML Investment Partners, L.P.
- Reporting Manager
- BML Investment Partners, L.P.
- Symbol
- EPIX
- Shares outstanding
- 44,502,372 shares
- Disclosed Ownership
- 4,183,223 shares
- Ownership
- 9.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 09:49:47 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 24 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BML Investment Partners, L.P. disclosed 9.4% ownership in ESSA Pharma Inc. Common Shares, no par value per share (EPIX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 09:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BML Investment Partners, L.P. | 9.4% | 4,183,223 | 0 | 4,183,223 | Braden M Leonard | BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member |